Bryan Dechairo

Bryan Dechairo is an experienced executive in the diagnostics and biotechnology sectors. Currently serving as Chief Operating Officer at GeneDx since January 2025, Bryan previously held significant leadership roles including President and CEO at Sherlock Biosciences, where over $80 million in venture financing was secured, and Director on the Board of Biocartis, focusing on innovative molecular testing solutions. Bryan has also contributed to Myriad Genetics as Executive Vice President of Development, optimizing clinical portfolios, and served as Chief Medical Officer at Assurex Health, advancing novel technologies and securing payer reimbursement. Additional experience includes leadership roles at Medco Health, Pfizer Inc., and Oxagen Ltd., with a strong academic foundation in Human Genetics (PhD) from UCL and Integrative Biology (BA) from the University of California, Berkeley.